Needham & Company LLC reiterated their buy rating on shares of Generation Bio (NASDAQ:GBIO – Get Rating) in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a $14.00 price target on the stock. Separately, JMP Securities lowered their price objective on Generation Bio from $7.00 to $2.23 and set a […]